XML 44 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities:    
Net income $ 456,000,000 $ 384,000,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Deferred income taxes 140,000,000 65,000,000
Depreciation and amortization 24,000,000 23,000,000
Amortization and write-off of capitalized software development costs and intellectual property licenses 83,000,000 30,000,000
Stock-based compensation expense 27,000,000 21,000,000
Excess tax benefits from stock option exercises (4,000,000) (2,000,000)
Changes in operating assets and liabilities:    
Accounts receivable, net 465,000,000 553,000,000
Inventories, net 47,000,000 0
Software development and intellectual property licenses (73,000,000) (67,000,000)
Other assets 91,000,000 174,000,000
Deferred revenues (511,000,000) (576,000,000)
Accounts payable (149,000,000) (215,000,000)
Accrued expenses and other liabilities (271,000,000) (237,000,000)
Net cash provided by operating activities 325,000,000 153,000,000
Cash flows from investing activities:    
Proceeds from maturities of available-for-sale-investments 113,000,000 115,000,000
Purchases of available-for-sale investments (26,000,000) (187,000,000)
Capital expenditures (17,000,000) (9,000,000)
(Increase) decrease in restricted cash 10,000,000 4,000,000
Net cash provided by (used in) investing activities 80,000,000 (77,000,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock to employees 33,000,000 15,000,000
Tax payment related to net share settlements of restricted stock rights (14,000,000) (2,000,000)
Repurchase of common stock 0 (261,000,000)
Excess tax benefits from stock option exercises 4,000,000 2,000,000
Net cash provided by (used in) financing activities 23,000,000 (246,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents (88,000,000) 54,000,000
Net increase (decrease) in cash and cash equivalents 340,000,000 (116,000,000)
Cash and cash equivalents at beginning of period 3,959,000,000 3,165,000,000
Cash and cash equivalents at end of period $ 4,299,000,000 $ 3,049,000,000